PLK2 and Parkinson disease: A further underlying mechanism of the isolated flavonoid in modulating PD was partially anticipated by performing in silico molecular docking and molecular dynamic (MD) simulation analysis against selected PD-related neurogenic targets such as human acetylcholine esterase (AChE), monoamine oxidase B (MAO-B), and Polo-like kinase-2 (PLK2).